These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7815460)

  • 1. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids.
    Hüsken BC; de Jong J; Beekman B; Onderwater RC; van der Vijgh WJ; Bast A
    Cancer Chemother Pharmacol; 1995; 37(1-2):55-62. PubMed ID: 7497597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A; Kaiserová H; den Hartog GJ; Haenen GR; van der Vijgh WJ
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
    Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species.
    de Jong J; Schoofs PR; Onderwater RC; van der Vijgh WJ; Pinedo HM; Bast A
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):275-89. PubMed ID: 2166963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
    van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
    Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biotransformation in anthracycline-induced cardiotoxicity in mice.
    de Jong J; Schoofs PR; Snabilié AM; Bast A; van der Vijgh WJ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1312-20. PubMed ID: 8371139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.
    Herman EH; Zhang J; Ferrans VJ
    Cancer Chemother Pharmacol; 1994; 35(2):93-100. PubMed ID: 7987999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
    Alderton P; Gross J; Green MD
    Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse.
    Flandina C; Sanguedolce R; Rausa L; D'Alessandro N
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
    Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.
    Hašková P; Koubková L; Vávrová A; Macková E; Hrušková K; Kovaříková P; Vávrová K; Simůnek T
    Toxicology; 2011 Nov; 289(2-3):122-31. PubMed ID: 21864640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin.
    Xu LJ; Jin L; Pan H; Zhang AZ; Wei G; Li PP; Lu WY
    Acta Pharmacol Sin; 2006 Oct; 27(10):1333-9. PubMed ID: 17007740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac DT-diaphorase contributes to the detoxification system against doxorubicin-induced positive inotropic effects in guinea-pig isolated atria.
    Badary OA; Awad AS; Abdel-Maksoud S; Hamada FM
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):856-61. PubMed ID: 15659049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.